LURBIRO
- Product NDC
- 71085-082
- 11-digit product format
- 710850082
- Labeler code
- 71085
- Product ID
- 71085-082_3b2b98e9-9358-52c6-e063-6394a90a3758
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Flurbiprofen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- IPG Pharmaceuticals, Inc.
- Application
- ANDA074431
- Marketing category
- ANDA
- Marketing start
- 2025-08-01
- Substance
- FLURBIPROFEN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LURBIRO
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FLURBIPROFEN | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5GRO578KLP |
| Rxcui | 197724, 2720355 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71085-082-30 | LURBIRO | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71085-082-30 | 71085008230 | 30 TABLET in 1 BOTTLE (71085-082-30) | 30 tablet | 2025-08-01 | No | No | Historical |